Researchers quantify presence of immunotherapy biomarkers in breast cancer – Healio
|
Researchers quantify presence of immunotherapy biomarkers in breast cancer
Healio SAN ANTONIO — Although a minority of patients with invasive breast cancer expressed microsatellite instability, high tumor mutational load or PD-L1 expression, these biomarkers may elucidate the benefit of immune checkpoint inhibitors for the disease … |
